Biocept Enters into $10M Credit Facility | GenomeWeb

NEW YORK (GenomeWeb) – Biocept has entered into a $10 million loan and security agreement with Oxford Finance, the San Diego-based oncology diagnostics firm said in a US Securities and Exchange document on Tuesday.

Biocept received a $5 million loan on April 30 and will receive another $5 million loan prior to Dec. 31, 2015, subject to the firm achieving at least $9 million in product and service revenues for a six-month period ending no later than Nov. 30, 2015.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.